Qube Research & Technologies LTD Co Diagnostics, Inc. Call Options Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CODX
# of Institutions
48Shares Held
4.37MCall Options Held
30.7KPut Options Held
122K-
Vanguard Group Inc Valley Forge, PA1.78MShares$2.08 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny568KShares$664,2340.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$587,3690.0% of portfolio
-
Geode Capital Management, LLC Boston, MA321KShares$375,8910.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$319,2930.01% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $39.5M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...